MedTrace Logo

Influence of Physostigmine on Patient-Controlled Analgesia (PCA) in Postoperative Intensive Care Patients

NCT00608621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2008-02-06

No results posted yet for this study

Summary

The study is to evaluate the influence of physostigmine in the postoperative period in intensive care patients considering pain quality, opioid consumption, hemodynamics and mobilisation.

Conditions

Sponsors & Collaborators

  • University of Mannheim

    collaborator OTHER

  • Klinikum Ludwigshafen

    lead OTHER

Principal Investigators

  • Christoph Konrad, Prof. · University Hospital Mannheim, Department of Anesthesiology

  • Kerstin D. Roehm, MD · Klinikum Ludwigshafen, Department of Anesthesiology

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00608621 on ClinicalTrials.gov